TSHA

TSHA Cost of Revenue

$880.00KTTM · USD

Period ending:

TSHA FY Cost of RevenueUSD
TSHA FY Cost of Revenue2019-12-31: $0.002020-12-31: $9.00K2021-12-31: $0.002022-12-31: $2.49M2023-12-31: $0.002024-12-31: $0.002025-12-31: $0.00$2.49M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TSHA cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
0
0
0
2,487,000
0
9,000
0

Compare cost of revenue

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.